"Research Highlights: Genetic Association of the Dopamine Receptor D3 Ser9Gly Polymorphism with a DRD3 Antagonist." Personalized Medicine, 10(7), pp. 631–632
Financial & competing interests disclosure
This work was funded by Vita Genomics, Inc., the National Science Council, Taiwan (NSC-101-2314-B-039-030-MY3 and NSC-101-2325-B-039-009), Department of Health Clinical Trial and Research Center of Excellence in Taiwan (DOH102-TD-B-111-004), and China Medical University Hospital, Taiwan (CMU 101-AWARD-13, DMR-100-117 and DMR-100-119). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Additional information
Funding
This work was funded by Vita Genomics, Inc., the National Science Council, Taiwan (NSC-101-2314-B-039-030-MY3 and NSC-101-2325-B-039-009), Department of Health Clinical Trial and Research Center of Excellence in Taiwan (DOH102-TD-B-111-004), and China Medical University Hospital, Taiwan (CMU 101-AWARD-13, DMR-100-117 and DMR-100-119). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.